本页面由Tiger Trade Technology Pte. Ltd.提供服务

亘喜生物

10.25
0.0000
成交量:- -
成交额:6,573.27万
市值:9.91亿
市盈率:-10.79
高:10.25
开:10.25
低:10.25
收:10.25
52周最高:10.44
52周最低:1.40
股本:9,671.24万
流通股本:3,327.85万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.9502
每股收益(LYR):-1.3016
净资产收益率:-31.57%
总资产收益率:-19.41%
市净率:4.15
市盈率(LYR):-7.87

数据加载中...

2023/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/04/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/13

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/31

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/01

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/06

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/17

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/19

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals